Chinese health expert says bribery adds 20% to drug costs

07/29/2013 | Xinhuanet.com (China)

Paying bribes can add as much as 20% to the costs of typical Chinese medications, according to Yu Mingde, chief of the China Pharmaceutical Enterprises Association. He estimates that legitimate sales and marketing expenses, plus illicit disbursement like bribery, accounts for 30% to 40% of a drug’s costs. Yu urged that solid market systems be established and stronger punishments be given to those who violate the law.

View Full Article in:

Xinhuanet.com (China)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park